{
    "clinical_study": {
        "@rank": "105772", 
        "arm_group": [
            {
                "arm_group_label": "State-of-the-art mouth care", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "Mouth rinse Caphosol", 
                "arm_group_type": "Active Comparator", 
                "description": "Mouth rinse,aqueous solution. Caphosol is a preparation comprising two separately packaged aqueous solutions, a phosphate solution and a calcium solution, which, when both solutions are combined in equal volumes, forms a solution supersaturated with respect to both calcium and phosphate ions."
            }
        ], 
        "brief_summary": {
            "textblock": "Randomized controlled study about the efficacy of the mouth rinse Caphosol in patients with\n      allogeneic stem cell transplantation. 85% of the patients receive a severe oral mucositis\n      due to their treatment.\n\n      70 patients will be randomized in the intervention (Caphosol) or in the standard\n      (state-of-the-art) group. Primary endpoint is the duration of the mucositis, secondary\n      endpoints are the occurence of oral mucositis measured with the WHO-scale and the occurence\n      of pain measured with the NRS-scale (Numeric Rating Scale).\n\n        -  Trial with medical device"
        }, 
        "brief_title": "Caphosol\u00ae Versus State-of-the-art Mouthcare in Patients With Allogeneic Stem Cell Transplantation: a Randomized Controlled Study About the Efficacy of the Mouth Rinse Caphosol\u00ae", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Allogeneic Stem Cell Transplantation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Allogeneic stem cell transplantation\n\n          -  Male and female patients age 18-80\n\n          -  Signed informed consent after information\n\n        Exclusion criteria:\n\n          -  Contra-indications due to ethical reasons\n\n          -  Unable to read or write\n\n          -  Unable to speak or understand the german language\n\n          -  Low-salt diet"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01758562", 
            "org_study_id": "Capo"
        }, 
        "intervention": {
            "arm_group_label": "Mouth rinse Caphosol", 
            "intervention_name": "Caphosol", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "state": "ZH", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich, Centre of Clinical Nursing Science"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "anja.kroener@usz.ch", 
            "last_name": "Anja Katharina Kroener", 
            "phone": "+41 (0)44 255 11 11"
        }, 
        "overall_contact_backup": {
            "email": "rebecca.spirig@usz.ch", 
            "last_name": "Rebecca Spirig, Prof MD"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Zurich, Centre of Clinical Nursing Science", 
            "last_name": "Rebecca Spirig, Prof MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Duration of oral mucositis", 
            "safety_issue": "No", 
            "time_frame": "20-30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01758562"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}